Müller Thomas F, Schröder Ronald, Wysocki Patrick, Mettenleiter Thomas C, Freuling Conrad M
Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, Greifswald-Insel Riems, Germany.
Institute of Epidemiology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
PLoS Negl Trop Dis. 2015 Aug 17;9(8):e0003953. doi: 10.1371/journal.pntd.0003953. eCollection 2015.
In Europe, the elimination of wildlife rabies using oral rabies vaccination [ORV] of foxes for more than 30 years has been a success story. Since a comprehensive review on the scope of the different oral rabies vaccine baits distributed across Europe has not been available yet, we evaluated the use of different vaccine baits over the entire period of ORV [1978-2014]. Our findings provide valuable insights into the complexity of ORV programs in terms of vaccine related issues. More than 10 oral vaccines against rabies were used over the past four decades. Depending on many factors, the extent to which oral rabies virus vaccines were used varied considerably resulting in huge differences in the number of vaccine doses disseminated in ORV campaigns as well as in large spatial and temporal overlaps. Although vaccine virus strains derived from the SAD rabies virus isolate were the most widely used, the success of ORV campaigns in Europe cannot be assigned to a single oral rabies virus vaccine alone. Rather, the successful elimination of fox rabies is the result of an interaction of different key components of ORV campaigns, i.e. vaccine strain, vaccine bait and strategy of distribution.
在欧洲,使用狐狸口服狂犬病疫苗(ORV)消除野生动物狂犬病已有30多年,这是一个成功的案例。由于尚未有对欧洲各地分发的不同口服狂犬病疫苗诱饵范围的全面综述,我们评估了在整个ORV期间(1978 - 2014年)不同疫苗诱饵的使用情况。我们的研究结果为ORV项目在疫苗相关问题方面的复杂性提供了有价值的见解。在过去的四十年里,使用了超过10种口服狂犬病疫苗。由于多种因素,口服狂犬病病毒疫苗的使用程度差异很大,导致ORV活动中分发的疫苗剂量数量有巨大差异,以及在空间和时间上有很大的重叠。尽管源自SAD狂犬病病毒分离株的疫苗病毒株使用最为广泛,但欧洲ORV活动的成功不能仅归因于单一的口服狂犬病病毒疫苗。相反,狐狸狂犬病的成功消除是ORV活动不同关键组成部分相互作用的结果,即疫苗株、疫苗诱饵和分发策略。